Quest Diagnostics company profile
Company profile
Quest Diagnostics has 60,000 employees and is headquartered in Secaucus, United States.
Based in Secaucus, New Jersey, and operating since 1967, the company runs a network of laboratories and patient service centers that handles routine and advanced clinical tests, anatomic pathology, and genetic screening for prenatal care. Its services reach physicians, hospitals, patients, employers, insurers, and government agencies across the US, with brands including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum alongside its own name. Workplace drug testing, toxicology, and underwriting support for life insurers are among its offerings, and it also develops in vitro diagnostic tests.
In the fiscal year ended December 2025, revenue rose 11.8% to 11.0 billion dollars, and net income reached 992 million dollars. The company employs 60,000 people and is headquartered in Secaucus, New Jersey.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Headquarters
- 500 Plaza Drive, 07094, Secaucus
- Employees
- 60,000
- Chief executive
- James Davis
- Founded
- 1967
- Fiscal year
- January - December
- Listing
- DGX · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US74834L1008
- Website
- questdiagnostics.com
Quest Diagnostics and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Quest DiagnosticsDGX | United States | $28.56B | 60,000 | 14.9% | 25.9 |
| Labcorp HoldingsLH | United States | $30.08B | 71,000 | 11.2% | 30.4 |
| IlluminaILMN | United States | $31.3B | 8,600 | 19.1% | 36.1 |
| Mettler-Toledo InternationalMTD | United States | $34.59B | 16,600 | 27.8% | 37.7 |
| Guardant HealthGH | United States | $20.52B | 2,490 | -39.4% | — |
| Medpace HoldingsMEDP | United States | $19.12B | 6,600 | 21.4% | 38.0 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
